PREVALENCE OF CO-MEDICATION AND POTENTIAL DRUG-DRUG INTERACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY

Journal Title: Indo American Journal of Pharmaceutical Research - Year 2017, Vol 7, Issue

Abstract

Abstract Background:-Drug interaction is an important therapeutic challenge among Human Immunodeficiency Virus infected patients. They are often observed in these patients because they frequently receive multiple medications. Though this may have clinical and economic impact, its prevalence is unknown in Ethiopia. So this study was aimed at addressing this issue by determining the prevalence of Co-medication and potential drug-drug interaction (PDDIs) in HIV infected patients. Method:- initially, checklist containing the relevant variables for the study was developed; ethical approval for patient medical history card (PMHC) access was requested and obtained from the hospital. Then, before the actual data collection process takes place, pre-test was done on 18 PMHCs. After assessing the check list, data of 350 HIV infected patients was reviewed retrospectively and recorded from cards using simple random sampling method. Subsequently, PDDI was assessed using Meds cape online drug interaction checker database and Drug.com (as supportive DDI checker). Then, the data was checked for completeness, entered and analyzed using Statistical Package for Social Science (SPSS) version 20 and Microsoft excel and presented using tables and figures. Result:-out of 350 HIV infected patients on HAART; only 53(15.1%) patients were not co-medicated along with Anti-Retroviral drugs. Then, a total of 2431 PDDIs were identified, and pharmacokinetic and pharmacodynamic interactions were found to occur almost in comparable frequency and almost all of the interactions were found to be moderate or minor in their severity. Conclusion:-in this study more than half of the HIV infected patients were found co-medicated and high numbers of PDDIs were identified. Accordingly, the authors of this study concluded that co-medication and PDDIs are common and, though unavoidable, since almost all of the identified PDDIs were moderate or minor in their severity, the authors’ recommend close monitoring of patients for therapeutic or toxic response.

Authors and Affiliations

Keywords

Related Articles

PATTERN OF RESEARCHES DONE ON ANTIMICROBIAL RESISTANCE IN ETHIOPIA

Abstract Background: Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. In recent years, since the...

FORMULATION AND EVALUATION OF OMEPRAZOLE MICROSPHERES BY DIFFERENT TECHNIQUES

Abstract The intention behind the present work was to develop a microsphere based novel dosage form for sustained delivery of Omeprazole. Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion by sp...

Formulation and Evaluation of L-arginine Sustained Release Tablets

L-Arginine is an amino acid that has numerous functions in the body. In the body L-Arginine is used to make nitric oxide which reduces blood vessels Stiffness, increases blood flow and improves blood vessel function. L-A...

PHARMACOPHORE MODELLING FOR THE DISCOVERY OF SYSTEM XC- ANTIPORTER INHIBITORS

Abstract Cancer is one of the major disorders with increasing rates of morbidity and mortality. Recent drug discovery of anti cancer drug has identified several molecular targets and tried to achieve a goal of therapeuti...

FORMULATION AND EVALUATION OF DICLOFENAC NIOSOMAL DRUG DELIEVERY SYSTEMS

In order to establish and maintain drugs from any concentrations at target sites for a longer period of time, niosomes was formulated. The main aim of this study was to formulate niosomal suspension containing diclofenac...

Download PDF file
  • EP ID EP330942
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

(2017). PREVALENCE OF CO-MEDICATION AND POTENTIAL DRUG-DRUG INTERACTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY. Indo American Journal of Pharmaceutical Research, 7(), -. https://europub.co.uk/articles/-A-330942